- Oops!Something went wrong.Please try again later.
Spectrum Pharmaceuticals, Inc. SPPI was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.81 to $3.32 in the past one-month time frame.
The company has seen two positive estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for Spectrum Pharma. So, make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Spectrum Pharma currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Spectrum Pharmaceuticals, Inc. Price
Spectrum Pharmaceuticals, Inc. price | Spectrum Pharmaceuticals, Inc. Quote
Another stock worth considering in the Medical - Drugs industry is Translate Bio, Inc. TBIO which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2021.
Click here for the 6 trades >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Spectrum Pharmaceuticals, Inc. (SPPI) : Free Stock Analysis Report
Translate Bio, Inc. (TBIO) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research